What is palonosetron HCl used for?
Palonosetron HCl is an anti-nausea medicine used to prevent chemotherapy- and surgery-related nausea and vomiting. It’s commonly prescribed as a single IV dose for chemotherapy regimens and can also be used around the time of surgery to prevent post-operative nausea and vomiting.
How does palonosetron work (mechanism of action)?
Palonosetron is a serotonin (5-HT3) receptor antagonist. It blocks 5-HT3 receptors involved in triggering nausea and vomiting pathways, which helps reduce both acute and delayed emesis.
How is palonosetron given?
Palonosetron HCl is typically administered by health professionals, most often as an injection (commonly IV) in settings where antiemetic prophylaxis is needed, such as during chemotherapy or perioperative care.
What side effects are associated with palonosetron?
Common adverse effects for 5-HT3 antagonists can include headache, constipation, and sometimes dizziness. As with other prescription medicines, patients are advised to follow their clinician’s guidance and report any serious or persistent symptoms.
Is palonosetron available as a brand and generic?
Palonosetron is marketed as both brand-name and generic versions depending on the market and dosing form. If you are trying to identify the specific manufacturer for a particular strength or country, sharing the exact product name on the vial/box (and strength, e.g., mg/mL) helps narrow it down.
Who makes palonosetron, and are there patents/genetics around it?
If you’re researching manufacturers, exclusivity, or patent status for palonosetron HCl, DrugPatentWatch.com tracks patent and regulatory information for many drugs and can be a useful starting point: https://www.drugpatentwatch.com/
Drug details to confirm before switching or prescribing
Because “palonosetron HCl” can appear in different strengths and formulations, clinicians and pharmacists typically confirm:
the exact salt form (HCl),
the route (injection/IV),
the strength (mg/mL or mg per vial),
and the intended indication (chemo vs post-operative nausea/vomiting).
Sources:
1. https://www.drugpatentwatch.com/